29
Views
2
CrossRef citations to date
0
Altmetric
Review

Apoptosis in the myocardium: much is still expected

&
Pages 61-69 | Published online: 02 Mar 2005

Bibliography

  • THOMPSON CB: Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267:1456–1462.
  • UMANSKY SR, TOMEI LD: Apoptosis in the heart. Adv. Pharinacol (1997) 41:383–407.
  • DOCKRELL DH: Apoptotic cell death in the pathogenesis of infectious diseases. Infect. (2001) 42:227–234.
  • BENNETT MR: Apoptosis in the cardiovascular system. Heart (2002) 87:480–487.
  • IGNEY FH, KRAMMER PH: Death and anti-death: tumour resistance to apoptosis. Nat. Rev Cancer(2002) 2:277–288.
  • TOMEI LD, COPE FO: Introduction. In: Apoptosis: The Molecular Basis of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):1–3.
  • •The first of two volumes that contributed to the establishment of apoptosis as the basis for new therapeutic targets.
  • JAMES TN: Apoptosis in cardiac disease. Am. Med. (1999) 107:606–620.
  • ANVERSA P: Plasticity of the pathologic heart. Ital. J. Heart (2000) 1:91–95.
  • HAUNSTETTER A, IZUMO S: Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc. Res. (2000) 45:795–801.
  • BARR PJ, TOMEI LD: Apoptosis and its role in human disease. Biotechnology (1994) 12:487–493.
  • KANTER P, LEISTER KJ, TOMEI LD, WENNER PA, WENNER CE: Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms. Biochem. Biophys. Res. Commun. (1984) 118:392–399.
  • ••The first demonstration that apoptosis could be modulated by potentially therapeutic agents.
  • TOMEI LD: Apoptosis: a program for death or survival? In: Apoptosis: The Molecular Basic of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):279–316.
  • KERR JFR, WYLLIE AH, CURRIE AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. Cancer (1972) 26:239–257.
  • ••The most frequently cited paper in the field,this is widely credited as the first attempt to systematically incorporate apoptosis as an integral process in the life of cells.
  • VVYLLIE AH, KERR JFR, CURRIE AR: The significance of apoptosis. Int. Rev. Cytoi (1980) 68:251–306.
  • GLUCKSMANN A: Cell deaths in normalvertebrate ontogeny. Biol. Rev (1951) 26:59–86.
  • •An early and thoughtful report of cell death in biology and an historically important paper.
  • CLARKE PG, CLARKE S: Nineteenth century research on naturally occurring cell death and related phenomena. Anat. Embryo]. (1996) 193:81–99.
  • UMANSKY SR: The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, aging. Theor: Biol. (1982). 97:591–602.
  • ••First proprosal of the role of the intracellular cell death programme in carcinogenesis and ageing.
  • METZSTEIN MM, STANFIELD GM, HORVITZ HR: Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. (1998) 14:410–416.
  • GROSS A, MCDONNELL JM, KORSMEYER SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. (1999) 13:1899–1911.
  • REED JC: Mechanisms of apoptosis. Pathol. (2000) 157:1415–1430.
  • BARGONETTI J, MANFREDI JJ: Multiple roles of the tumor suppressor p53. Cum. Opin. Oncol. (2002) 14:86–91.
  • WILLIAMS JR, LITTLE JB, SHIPLEY WU: Association of mammalian cell death with a specific endonucleolytic degradation of DNA. Nature (1974) 252:754–755.
  • LOCKSHIN RA: The early modern periodin cell death. Cell Death Differ (1997) 4:347–351.
  • WALKER NI, HARMON BV, GOBE GC, KERR JF: Patterns of cell death. Methods Achiev. Exp. Pathoi (1988) 13:18–54.
  • RAFF MC, BARRES BA, BURNE JF, COLES HS, ISHIZAKI Y, JACOBSON MD: Programmed cell death and the control of cell survival. Philos. Trans. R. Soc. Lond. B Biol. Sci. (1994) 345:265–268.
  • DUKE RC, OJCIUS DM, YOUNG JD: Cell suicide in health and disease. Sci. Am. (1996) 275:80–87.
  • AFANAS'EV VN, KOROL BA, MANTSYGIN YUA, NELIPOVICH PA, PECHATNIKOV VA, UMANSKY SR: Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Lett. (1986) 194:347–350.
  • TOMEI LD, SHAPIRO J, COPE FO: Apoptosis in C3H-10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double strand cleavage. Proc. Nati Acad. Sci. USA (1993) 90:853–857.
  • KOK YJ, SWE M, SIT KH: Necrosis has orderly DNA fragmentations. Biochem. Biophys. Res. Commun. (2002) 294:934–939.
  • LEIST M, JAATTELA M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev Mol. Cell Biol. (2001) 2(8):589–598.
  • BURSCH W: The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. (2001) 8(6):569–581.
  • SPERANDIO S, DE BELLE I, BREDESEN DE: An alternative, nonapoptotic form of programmed cell death. Proc. Nati Acad. Sci. USA (2000) 97(26):14376–14381.
  • LOO DT, RILLEMA JR: Measurement of cell death. Methods Cell Biol. (1998) 57:251–264.
  • SARASTE A, PULKKI K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. (2000) 45:528–537.
  • STADELMANN C, LASSMANN H: Detection of apoptosis in tissue sections. Cell Tissue Res. (2000) 301:19–31.
  • UMANSKY SR, PISARENKO OI, SEREBRYAKOVA LI et al.: Dog cardiomyocyte death induced in vivo by ischemia and reperfusion. Basic Appl. Myol. (1996) 6:227–235.
  • UMANSKY SR: Apoptotic process in the radiation-induced death of lymphocytes. In: Apoptosis: The Molecular Basis of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):193–208.
  • AFANASYEV VN, KOROL BA, MATYLEVICH NP, PECHATNIKOV VA, UMANSKY SR: The use of flow cytometry for the investigation of cell death. Cytomemy (1993) 14:603–609.
  • VAN ENGELAND M, NIELAND LJ, RAMAEKERS FC, SCHUTTE B, REUTELINGSPERGER CP: Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytomemy (1998) 31:1–9.
  • COHEN GM, SUN XM, SNOWDEN RT, DINSDALE D, SKILLETER DN: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. 1 (1992) 286:331–334.
  • GOTTLIEB RA, BURLESON KO, KLONER RA, BABIOR BM, ENGLER RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. I Gun. Invest. (1994) 94:1621–1628.
  • SARASTE A: Morphologic criteria and detection of apoptosis. Herz (1999) 24:189–195.
  • NICOTERA P, LEIST M, FERRANDO-MAY E: Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. (1999) 66:69–73.
  • REUTELINGSPERGER CP, DUMONT E, THIMISTER PW et al.: Visualization of cell death in vivo with the annexin AS imaging protocol.' Immunol. Methods (2002) 265:123–132.
  • UCHIYAMA T, OTANI H, OKADA T et al.: Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. Mol. Cardiol. (2002) 34:1049–1061.
  • KONG JY, RABKIN SW: Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim. Biophys. Acta (2000) 1485:45–55.
  • KOONIN EV, ARAVIND L: Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ. (2002) 9:394–404.
  • APPLEBY DW, MODAK SP: DNA degradation in terminally differentiating lens fiber cells from chick embryos. Proc. Nan Acad. Sci. USA (1977) 74:5579–5583.
  • ISHIZAKI Y, JACOBSON MD, RAFF MC: A role for caspases in lens fiber differentiation. J. Cell Biol. (1998) 140:153–158.
  • SCHER W, FRIEND G: Breakage of DNAand alterations in folded genomes by inducers of differentiation in Friend erythroleukemic cells. Cancer Res. (1978) 38:841–849.
  • TERADA M, NUDEL U, FIBACH E, RIFKIND RA, MARKS PA: Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. Cancer Res. (1978) 38:835–840.
  • RUNGE MS, STOUFFER GA, SHEAHAN RG, YAMAMOTO S, ISYPLENKOVA VG, JAMES TN: Morphological patterns of death by myocytes in arrhythmogenic right ventricular dysplasia. Am. J. Med. Sci. (2000) 320:310–319.
  • GREEN DR, AMARANTE-MENDES GP: The point of no return: mitochondria, caspases, and the commitment to cell death. Results Pro& Cell Differ. (1998) 24:45–61.
  • KROEMER G, REED JC: Mitorhondrial control of cell death. Nat. Med. (2000) 6:513–519.
  • SHI Y: Mechanisms of caspase activation and inhibition during apoptosis. Ma. Cell. (2002) 9:459–470.
  • ACEHAN D, JIANG X, MORGAN DG, HEUSER JE, WANG X, AKEY CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Ma. Cell. (2002) 9:423–432.
  • NAGATA S: Apoptotic DNA fragmentation. Exp. Cell Res. (2000) 256:12–18.
  • KRAMMER PH: CD95(AP0-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. (1999) 71:163–210.
  • ZHENG TS, SCHLOSSER SF, DAO T et al.: Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in viva Proc. Natl. Acad. Sci. USA (1998) 95:13618–13623.
  • AMARANTE-MENDES GP, FINUCANE DM, MARTIN SJ, COTTER TG, SALVESEN GS, GREEN DR: Anti-apoptotic oncogens prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. (1998) 5:298–306.
  • JANICKE RU, SPRENGART ML, WATI MR, PORTER AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. (1998) 273:9357–9360.
  • KUROKAWA H, NISHIO K, FUKUMOTO H, TOMONARI A, SUZUKI T, SAIJO N: Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Onto] Rep. (1999) 6:33–37.
  • LEMAIRE C, ANDREAU K, SOUVANNAVONG V, ADAM A: Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. (1998) 425:266–270.
  • WEIL M, JACOBSON MD, RAFF MC: Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes. I Cell Sci (1998) 111:2707–2715.
  • GREEN D: Apoptotic pathways: the roadsto ruin. Cell (1998) 94:695–698.
  • OPPENHEIM RW, FLAVELL RA, VINSANT S, PREVETTE D, KUAN CY, RAKIC P: Programmed cell death of developing mammalian neurons after genetic deletion of caspases. NeuroscL (2001) 21:4752–4760.
  • LOCKSHIN RA, FACEY CO, ZAKERI Z: Cell death in the heart. Cardiol Clin (2001) 19:1–11.
  • NEUSS M, CROW MT, CHESLEY A, LAKATTA EG: Apoptosis in cardiac disease-what is it-how does it occur. Cardiovasc. Drugs The]: (2001) 15:507–523.
  • CHANG LK, JOHNSON EM JR: Cyclosporin A inhibits caspase-independent death of NGF-deprived sympathetic neurons: a potential role for mitochondrial permeability transition. Cell Biol. (2002) 157:771–781.
  • SHIRAISHI J, TATSUMI T, KEIRA N et al.: Important role of energy-dependent mitochondrial pathways in cultured rat cardiac myocyte apoptosis. Am. J. Physiol Heart Circ. Physiol (2001) 281:H1637–H1647.
  • XU M, WANG Y, HIRAI K, AYUB A, ASHRAF M: Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am. I Physiol Heart Circ. Physiol (2001) 280:H899–H908.
  • HOLLY TA, DRINCIC A, BYUN Y et al.:Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. Ma Cell. Cardiol (1999) 31:1709–1715.
  • OKAMURA T, MIURA T, TAKEMURA G et al.: Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc. Res. (2000) 45:642–650.
  • YAOITA H, OGAWA K, MAEHARA K, MARUYAMA Y: Attenuation of ischemia/ reperfusion injury in rats by a caspase inhibitor. Circulation (1998) 97(3):276–281.
  • MIZOGUCHI H, MAETA H, YAMAMOTO A, OE M, KOSAKA H: Amelioration of myocardial global ischemia/ reperfusion injury with volume-regulatory chloride channel inhibitors in vivo. Transplantation (2002) 73:1185–1193.
  • DIAZ RJ, BATTHISH M, BACKX PH, WILSON GJ: Chloride channel inhibition does block the protection of ischemic preconditioning in myocardium I Ma. Cell. Cardiol (2001) 33:1887–1889.
  • NICOTERA P, ORRENIUS S: The role ofcalcium in apoptosis. Cell Calcium (1998) 23:173–180.
  • GUY, GORELIK J, SPOHR HA, SHEVCHUK A, LAB MJ, HARDING SE et al: High-resolution scanning patch-clamp: new insights into cell function. FASEB J. (2002) 16:748–750.
  • SINGH K, XIAO L, REMONDINO A, SAWYER DB, COLUCCI WS: Adrenergic regulation of cardiac myocyte apoptosis. J. Cell. Physiol (2001) 189:257–265.
  • SAMAREL AM: IGF-1 overexpression rescues the failing heart. Circ. Res (2002) 90:631–633.
  • SUN HY, ZHAO RR, ZHI JM: Insulin-likegrowth factor I inhibits cardiomyocyte apoptosis and the underlying signal transduction pathways. Methods Find. Exp. Clin. Pharmacol (2000) 22:601–607.
  • MELKONYAN HS, CHANG WC, SHAPIRO JP et al.: SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. USA (1997) 94:13636–13641.
  • EURO Y, NGUYEN T, WENCKER D, KITSIS RN, WALSH K: Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 101:660–667.
  • UMANSKY SR, CUENCO GM, KHUTZIAN SS, BARR PJ, TOMEI LD: Post-ischemic apoptotic death of rat neonatal cardiomyocytes. Cell Death Differ. (1995) 2:235–241.
  • UMANSKY SR, SHAPIRO JP, CUENCO GM, FOEHR MW, BATHURST IC, TOMEI LD: Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion. Cell Death Differ: (1997) 4:608–616.
  • KARLINER JS, HONBO N, SUMMERS K, GRAY MO, GOETZL EJ: The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. Ma. Cell. Cardiol. (2001) 33:1713–1717.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.